Cover Image

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy

Introduction: Hypertrophic cardiomyopathy (HCM) is a leading cause of lethal arrhythmias in the young. Although the arrhythmic substrate has been hypothesised to be amenable to late Na+ block with ranolazine, the specific mechanisms are not fully understood. Therefore, this study aimed to investigat...

Full description

Saved in:

Bibliographic Details
Main Authors:	James A. Coleman (Author), Ruben Doste (Author), Matteo Beltrami (Author), Alessia Argirò (Author), Raffaele Coppini (Author), Iacopo Olivotto (Author), Betty Raman (Author), Alfonso Bueno-Orovio (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
by: Fitri Fareez Ramli, et al.
Published: (2022)

Management of Hypertrophic Cardiomyopathy
by: Alan D. Enriquez, et al.
Published: (2014)

Exercise Echocardiography in Hypertrophic Cardiomyopathy
by: Jesus Peteiro, et al.
Published: (2014)

Hypertrophic cardiomyopathy masked by pericarditis
by: Larry Nichols, et al.
Published: (2019)

Primary Hypertrophic Cardiomyopathy in Children
by: N.V. Nagornaya, et al.
Published: (2013)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021)

Apical pouches with hypertrophic cardiomyopathy
by: Fatih Mehmet Uçar, et al.
Published: (2014)

Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease
by: Sergio Caravita, et al.
Published: (2021)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015)

Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021)

Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features
by: Lanyan Guo, et al.
Published: (2023)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
by: M. S. Bychkova, et al.
Published: (2023)

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017)

Disopyramide as coadjuvant treatment in obstructive hypertrophic cardiomyopathy
by: Moisés Rodriguez-Gonzalez, et al.
Published: (2021)

Emerging clinical role of ranolazine in the management of angina
by: David S Vadnais, et al.
Published: (2010)

Ehlers-Danlos Syndrome associated with cardiomyopathy hypertrophic obstructive
by: Raimundo José Almeida de Oliveira Pinto, et al.
Published: (2015)

RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
by: Dong T, et al.
Published: (2023)

RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015)

A rare case of apical hypertrophic cardiomyopathy (AHCM)
by: Seyed Abbas Mirabbasi, et al.
Published: (2017)

Multiple left ventricular crypts in patient with hypertrophic cardiomyopathy
by: Fatih Bayrak, et al.
Published: (2016)

Hypertrophic cardiomyopathy with Jeune syndrome: The first reported case
by: Osman Güvenç, et al.
Published: (2016)

THE IMPORTANCE OF SEVERE CYTOLYSIS SYNDROME IN HYPERTROPHIC CARDIOMYOPATHY IN CHILDREN
by: Flavia-Crist, et al.
Published: (2017)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
by: Gabrielle Norrish, et al.
Published: (2021)

A case report of myocarditis masquerading as hypertrophic cardiomyopathy
by: Jaclyn R Giafaglione, et al.
Published: (2020)

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
by: O. Lorenzo, et al.
Published: (2013)

Proton Dependent Inhibition of the Cardiac Sodium Channel Nav1.5 by Ranolazine
by: Stanislav eSokolov, et al.
Published: (2013)

Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
by: Vera Paar, et al.
Published: (2023)

Comprehensive in vitro pro‐arrhythmic assays demonstrate that omecamtiv mecarbil has low pro‐arrhythmic risk
by: Yusheng Qu, et al.
Published: (2021)

Graded epidural anesthesia for fistulectomy with symptomatic obstructive hypertrophic cardiomyopathy
by: V Nivedha, et al.
Published: (2022)

Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants
by: Yu. N. Belenkov, et al.
Published: (2016)

HYPERTROPHIC CARDIOMYOPATHY AS A PART OF INHERITED MALFORMATION SYNDROMES IN INFANTS
by: M.V. Tural'chuk, et al.
Published: (2011)

Dual chamber pacing in obstructive hypertrophic cardiomyopathy. Preliminary information
by: Jesús Castro Hevia, et al.
Published: (2014)

A Machine Learning Approach to Gene Expression in Hypertrophic Cardiomyopathy
by: Jelena Pavić, et al.
Published: (2024)

Features of Diagnostics and Course of Hypertrophic Cardiomyopathy in Real Clinical Practice
by: E. V. Reznik, et al.
Published: (2023)

Editorial - 2014 European Society of Cardiology Guidelines on Hypertrophic Cardiomyopathy
by: Murat Özdemir
Published: (2014)

HYPERTROPHIC CARDIOMYOPATHY AS A PART OF INHERITED MALFORMATION SYNDROMES IN INFANTS
by: M.V. Tural'chuk, et al.
Published: (2011)

Hypertrophic Cardiomyopathy in the Elderly: A Case Identified With Genetic Screening
by: Gaspar Del Rio-Pertuz MD, et al.
Published: (2022)

Hypertrophic obstructive cardiomyopathy of an infant with neuroblastoma: a case report
by: Bültmann B, et al.
Published: (2007)